{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:33:10Z","timestamp":1763641990401},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Recombinant human soluble thrombomodulin (rhTM) is a novel anti-coagulant agent that regulates the imbalanced coagulation system by reducing the excessive activation of thrombin. rhTM potentially reduces the morbidity and mortality in patients with sepsis-induced disseminated intravascular coagulation (DIC). However, the efficacy of rhTM in obstetric DIC has not yet been established. We performed this study to examine whether the administration of rhTM was a potentially effective treatment for DIC induced by one or more underlying obstetric disorders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a single-center, retrospective cohort study conducted between January 2007 and February 2015 using the records of the Department of Obstetrics at the Perinatal Medical Center of TOYOTA Memorial Hospital, Aichi, Japan. The eligibility criteria were known or suspected obstetric DIC documented on the basis of clinical and laboratory data and association with one or more major underlying obstetric disorders. Baseline imbalance between patients with and without treatment of rhTM was adjusted using an inverse probability of treatment weighting using propensity scores composed of the following independent variables: severe postpartum hemorrhage, placental abruption, and preeclampsia\/eclampsia, including hemolysis, elevated liver enzymes, and low platelet syndrome, initial platelet counts, D-dimer levels, fibrinogen levels, and prothrombin time\u2013international normalized ratio (PT\u2013INR). We evaluated laboratory changes and clinical outcomes in the early phase of obstetric DIC.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In total, 66 of 4627 patients admitted to our department during the study period fulfilled the required criteria; of these, 37 and 29 patients were included in the rhTM and control group, respectively. After adjustment, treatment with rhTM was associated with significant improvements in platelet counts, D-dimer levels, fibrinogen levels, and PT\u2013INR compared with the control group. The platelet concentrate transfusion volume was significantly lower in the rhTM treatment group (3.02 vs 6.03 units,<jats:italic>P<\/jats:italic>\u2009=\u20090.016). None of the adjusted group differences were statistically significant for all types of organ damage and failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>rhTM administration was associated with clinical and laboratory improvement in patients with DIC caused by underlying obstetric conditions. Further clinical research is needed to clarify the optimal application of rhTM in each of the causative obstetric disorders.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13054-015-1086-3","type":"journal-article","created":{"date-parts":[[2015,10,14]],"date-time":"2015-10-14T00:41:50Z","timestamp":1444783310000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study"],"prefix":"10.1186","volume":"19","author":[{"given":"Masato","family":"Yoshihara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaname","family":"Uno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sho","family":"Tano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michinori","family":"Mayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Ukai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Kokabu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuyuki","family":"Kishigami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidenori","family":"Oguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,1]]},"reference":[{"key":"1086_CR1","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1046\/j.1365-2141.2003.04790.x","volume":"124","author":"M Levi","year":"2004","unstructured":"Levi M. Current understanding of disseminated intravascular coagulation. Br J Haematol. 2004;124:567\u201376.","journal-title":"Br J Haematol."},{"key":"1086_CR2","first-page":"00335","volume":"S0002-9378","author":"O Erez","year":"2015","unstructured":"Erez O, Mastrolia SA, Thachil J. Disseminated intravascular coagulation in pregnancy: insights in pathophysiology, diagnosis and management. Am J Obstet Gynecol. 2015;S0002-9378:00335.","journal-title":"Am J Obstet Gynecol."},{"key":"1086_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1097\/AOG.0b013e31826d60c5","volume":"120","author":"WM Callaghan","year":"2012","unstructured":"Callaghan WM, Creanga AA, Kuklina EV. Severe maternal morbidity and morbidity among delivery and postpartum hospitalizations in the United States. Obstet Gynecol. 2012;120:1029\u201336.","journal-title":"Obstet Gynecol."},{"key":"1086_CR4","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJMra1208626","volume":"370","author":"BJ Hunt","year":"2014","unstructured":"Hunt BJ. Bleeding and coagulopathies in critical care. N Engl J Med. 2014;370:847\u201359.","journal-title":"N Engl J Med."},{"key":"1086_CR5","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1055\/s-0037-1614900","volume":"82","author":"M Mohri","year":"1999","unstructured":"Mohri M, Sugimoto E, Sata M, Asano T. The inhibitory effect of recombinant human soluble thrombomodulin on initiation and extension of coagulation--a comparison with other anticoagulants. Thromb Haemost. 1999;82:1687\u201393.","journal-title":"Thromb Haemost."},{"key":"1086_CR6","doi-asserted-by":"publisher","first-page":"H1585","DOI":"10.1152\/ajpheart.00096.2013","volume":"304","author":"FA Martin","year":"2013","unstructured":"Martin FA, Murphy RP, Cummins PM. Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects. Am J Physiol Heart Circ Physiol. 2013;304:H1585\u201397.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"1086_CR7","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00134-013-2822-2","volume":"39","author":"K Yamakawa","year":"2013","unstructured":"Yamakawa K, Ogura H, Fujimi S, Morikawa M, Ogawa Y, Mohri T, et al. Recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Intensive Care Med. 2013;39:644\u201352.","journal-title":"Intensive Care Med."},{"key":"1086_CR8","doi-asserted-by":"publisher","first-page":"R123","DOI":"10.1186\/cc10228","volume":"15","author":"K Yamakawa","year":"2011","unstructured":"Yamakawa K, Fujimi S, Mohri T, Matsuda H, Nakamori Y, Hirose T, et al. Treatment effects of recombinant human soluble thrombomodulin in patients with severe sepsis: a historical control study. Crit Care. 2011;15:R123.","journal-title":"Crit Care."},{"key":"1086_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13054-015-0810-3","volume":"19","author":"J Yoshimura","year":"2015","unstructured":"Yoshimura J, Yamakawa K, Ogura H, Umemura Y, Takahashi H, Morikawa M, et al. Benefit profile of recombinant human soluble thrombomodulin in sepsis-induced disseminated intravascular coagulation: a multicenter propensity score analysis. Crit Care. 2015;19:78.","journal-title":"Crit Care."},{"key":"1086_CR10","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/CCM.0b013e31828e9b03","volume":"41","author":"JL Vincent","year":"2013","unstructured":"Vincent JL, Ramesh MK, Ernest D, LaRosa SP, Pachl J, Aikawa N, et al. A randomized, double-blind, placebo-controlled, Phase 2b study to evaluate the safety and efficacy of recombinant human soluble thrombomodulin, ART-123, in patients with sepsis and suspected disseminated intravascular coagulation. Crit Care Med. 2013;41:2069\u201379.","journal-title":"Crit Care Med."},{"key":"1086_CR11","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1177\/1076029612443305","volume":"19","author":"J Sugawara","year":"2013","unstructured":"Sugawara J, Suenaga K, Hoshiai T, Sato T, Nishigori H, Nagase S, et al. Efficacy of recombinant human soluble thrombomodulin in severe postpartum hemorrhage with disseminated intravascular coagulation. Clin Appl Thromb Hemost. 2013;19:557\u201361.","journal-title":"Clin Appl Thromb Hemost."},{"key":"1086_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1447-0756.1987.tb00001.x","volume":"13","author":"T Terao","year":"1987","unstructured":"Terao T, Maki M, Ikenoue T. A prospective study in 38 patients with abruptio placentae of 70 cases complicated by DIC. Asia Oceania J Obstet Gynaecol. 1987;13:1\u201313.","journal-title":"Asia Oceania J Obstet Gynaecol."},{"key":"1086_CR13","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1111\/jog.12426","volume":"40","author":"T Kobayashi","year":"2014","unstructured":"Kobayashi T. Obstetrical disseminated intravascular coagulation score. J Obstet Gynaecol Res. 2014;40:1500\u20136.","journal-title":"J Obstet Gynaecol Res."},{"key":"1086_CR14","unstructured":"Optimizing protocols in obstetrics. Management of obstetric hemorrhage. In: The American congress of Obstetrician and Gynecologist District II. 2012. http:\/\/www.acog.org\/~\/media\/Districts\/District%20II\/PDFs\/Final_Hemorrhage_Web.pdf. Accessed 30 Apr 2015."},{"key":"1086_CR15","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/01621459.1984.10478078","volume":"79","author":"PR Rosenbaum","year":"1984","unstructured":"Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516\u201324.","journal-title":"J Am Stat Assoc."},{"key":"1086_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1002\/sim.5991","volume":"33","author":"EJ Williamson","year":"2014","unstructured":"Williamson EJ, Forbes A, White IR. Variance reduction in randomised trials by inverse probability weighting using the propensity score. Stat Med. 2014;33:721\u201337.","journal-title":"Stat Med."},{"key":"1086_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1471-2326-12-10","volume":"12","author":"M Resche-Rigon","year":"2012","unstructured":"Resche-Rigon M, Pirracchio R, Robin M, De Latour RP, Sibon D, Ades L, et al. Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases. BMC Blood Disord. 2012;12:10.","journal-title":"BMC Blood Disord."},{"key":"1086_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/00031305.1985.10479383","volume":"39","author":"PR Rosenbaum","year":"1985","unstructured":"Rosenbaum PR, Rubin DB. Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Am Stat. 1985;39:33\u20138.","journal-title":"Am Stat."},{"key":"1086_CR19","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1152\/ajpheart.00096.2013","volume":"304","author":"FA Martin","year":"2013","unstructured":"Martin FA, Murphy RP, Cumminus PM. Thrombomodulin and the vascular endothelium: insights into functional, regulatory, and therapeutic aspects. Am J Physiol Heart Circ Physiol. 2013;304:1585\u201397.","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"1086_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00281-011-0282-8","volume":"34","author":"EM Conway","year":"2012","unstructured":"Conway EM. Thrombomodulin and its role in inflammation. Semin Immunopathol. 2012;34:107\u201325.","journal-title":"Semin Immunopathol."},{"key":"1086_CR21","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1055\/s-0038-1649597","volume":"70","author":"M Aritomi","year":"1993","unstructured":"Aritomi M, Watanabe N, Ohishi R, Gomi K, Kiyota T, Yamamoto S, et al. Recombinant human soluble thrombomodulin delivers bounded thrombin to antithrombin III: thrombomodulin associates with free thrombin and is recycled to activate protein c. Thromb Haemost. 1993;70:418\u201322.","journal-title":"Thromb Haemost."},{"key":"1086_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.thromres.2011.10.031","volume":"129","author":"M Colucci","year":"2012","unstructured":"Colucci M, Semeraro N. Thrombin activatable fibrinolysis inhibitor: at the nexus of fibrinolysis and inflammation. Thromb Res. 2012;129:314\u20139.","journal-title":"Thromb Res."},{"key":"1086_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1002\/med.21294","volume":"34","author":"L Wang","year":"2014","unstructured":"Wang L, Jiang R, Sun XL. Recombinant thrombomodulin of different domains for pharmaceutical, biomedical, and cell transplantation applications. Med Res Rev. 2014;34:479\u2013502.","journal-title":"Med Res Rev."},{"key":"1086_CR24","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1016\/S0002-9440(10)61230-8","volume":"167","author":"CJ Lockwood","year":"2005","unstructured":"Lockwood CJ, Toti P, Arcuri F, Paidas M, Buchwalder L, Krikun G, et al. Mechanisms of abruption-induced premature rupture of the fetal membranes: thrombin-enhanced interleukin-8 expression in term decidua. Am J Pathol. 2005;167:1443\u20139.","journal-title":"Am J Pathol."},{"key":"1086_CR25","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1160\/TH06-07-0387","volume":"97","author":"G Krikun","year":"2007","unstructured":"Krikun G, Huang ST, Schatz F, Salafia C, Stocco C, Lockwood CJ. Thrombin activation of endometrial endothelial cells: a possible role in intrauterine growth restriction. Thromb Haemost. 2007;97:245\u201353.","journal-title":"Thromb Haemost."},{"key":"1086_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.blre.2009.04.002","volume":"23","author":"J Thachil","year":"2009","unstructured":"Thachil J, Toh CH. Disseminated intravascular coagulation in obstetric disorders and its acute haematological management. Blood Rev. 2009;23:167\u201376.","journal-title":"Blood Rev."},{"key":"1086_CR27","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0146-0005(03)00022-3","volume":"27","author":"BM Sibai","year":"2003","unstructured":"Sibai BM, Caritis S, Hauth J, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. What we have learned about preeclampsia. Semin Perinatol. 2003;27:239\u201346.","journal-title":"Semin Perinatol"},{"key":"1086_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.semnephrol.2010.10.004","volume":"31","author":"SE Maynard","year":"2011","unstructured":"Maynard SE, Karumanchi SA. Angiogenic factors and preeclampsia. Semin Nephrol. 2011;31:33\u201346.","journal-title":"Semin Nephrol."},{"key":"1086_CR29","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1111\/j.1523-1755.2005.00316.x","volume":"67","author":"SA Karumanchi","year":"2005","unstructured":"Karumanchi SA, Maynard SE, Stillman IE, Epstein FH, Sukhatme VP. Preeclampsia: a renal perspective. Kidney Int. 2005;67:2101\u201313.","journal-title":"Kidney Int."},{"key":"1086_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1527-3466.2000.tb00055.x","volume":"18","author":"M Mohri","year":"2000","unstructured":"Mohri M. ART-123: recombinant human soluble thrombomodulin. Cardiovasc Drug Rev. 2000;18:312\u201325.","journal-title":"Cardiovasc Drug Rev."}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1086-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-015-1086-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1086-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-015-1086-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T19:54:06Z","timestamp":1718135646000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-015-1086-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1086"],"URL":"https:\/\/doi.org\/10.1186\/s13054-015-1086-3","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"15 May 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"369"}}